Ryota Kikuchi Selected Research

Ryota Kikuchi Research Topics

Disease

6	Neoplasms (Cancer) 12/2021 - 03/2010
5	Lung Neoplasms (Lung Cancer) 01/2021 - 01/2017
4	Interstitial Lung Diseases (Interstitial Lung Disease) 01/2022 - 01/2021
3	Inflammation (Inflammations) 01/2021 - 05/2015
3	Acidosis 12/2020 - 11/2017
2	Pneumonia (Pneumonitis) 05/2022 - 01/2015
2	COVID-19 05/2022 - 12/2020
2	Non-Small-Cell Lung Carcinoma (Carcinoma, Non-Small Cell Lung) 01/2022 - 01/2021
2	Chronic Obstructive Pulmonary Disease (COPD) 10/2021 - 10/2016
2	Asthma (Bronchial Asthma) 10/2021 - 10/2016
2	Pulmonary Eosinophilia (Eosinophilic Pneumonia) 01/2019 - 03/2014
2	Dyspnea (Shortness of Breath) 01/2019 - 01/2015
2	Hemorrhage 03/2018 - 01/2015
2	Pulmonary Emphysema 01/2017 - 08/2014
2	Fibrosis (Cirrhosis) 10/2016 - 05/2015
1	Vasculitis (Vasculitides) 06/2022
1	Takayasu Arteritis (Arteritis, Takayasu's) 06/2022
1	Sarcopenia 01/2022
1	Melanoma (Melanoma, Malignant) 12/2021
1	Pulmonary Fibrosis (Fibrosing Alveolitis) 07/2021
1	Small Cell Lung Carcinoma (Small Cell Lung Cancer) 01/2021
1	Respiratory Insufficiency (Respiratory Failure) 12/2020
1	Chronic Disease (Chronic Diseases) 07/2020
1	Chronic Hepatitis C 01/2019
1	Encephalitis (Encephalitis, Rasmussen) 01/2019
1	Breast Neoplasms (Breast Cancer) 01/2019
1	Virus Diseases (Viral Diseases) 01/2019
1	Fever (Fevers) 01/2019
1	Pulmonary Edema 03/2018
1	Biliary Atresia 02/2018
1	Hypercapnia 11/2017
1	Hypertrophy 11/2017
1	Hypocapnia 11/2017
1	Secondary Hypertrophic Osteoarthropathy 01/2017
1	Hyperplasia 10/2016

Drug/Important Bio-Agent (IBA)

3	Pharmaceutical PreparationsIBA 10/2021 - 11/2010
3	C-Reactive ProteinIBA 01/2021 - 01/2015
3	Proteins (Proteins, Gene)FDA Link 12/2020 - 11/2017
3	Peptides (Polypeptides)IBA 01/2019 - 03/2010
3	Messenger RNA (mRNA)IBA 11/2013 - 03/2010
2	Peroxisome Proliferator-Activated Receptors (PPAR)IBA 07/2021 - 11/2017
2	AlbuminsIBA 01/2021 - 01/2021
2	Glucose (Dextrose)FDA LinkGeneric 12/2020 - 01/2017
2	Adenosine Triphosphate (ATP)IBA 12/2020 - 11/2010
2	Antiviral Agents (Antivirals)IBA 01/2019 - 11/2010
2	Pancreatic Elastase (Elastase)IBA 01/2017 - 08/2014
2	AntigensIBA 01/2015 - 03/2014
2	AnionsIBA 11/2013 - 03/2010
2	Multidrug Resistance-Associated ProteinsIBA 11/2013 - 03/2010
1	Granulocyte Colony-Stimulating Factor (G-CSF)IBA 06/2022
1	Pulmonary Surfactant-Associated Protein D (Surfactant Protein D)IBA 05/2022
1	Biomarkers (Surrogate Marker)IBA 05/2022
1	SOXE Transcription FactorsIBA 12/2021
1	Histone Deacetylase InhibitorsIBA 12/2021
1	Therapeutic UsesIBA 10/2021
1	SmokeIBA 10/2021
1	GlucocorticoidsIBA 10/2021
1	OvalbuminIBA 10/2021
1	Dexamethasone (Maxidex)FDA LinkGeneric 10/2021
1	RoflumilastIBA 10/2021
1	PPAR alphaIBA 07/2021
1	LipidsIBA 07/2021
1	Fenofibrate (CiL)FDA LinkGeneric 07/2021
1	Adrenal Cortex Hormones (Corticosteroids)IBA 12/2020
1	favipiravirIBA 12/2020
1	Polymyxin B (Aerosporin)FDA LinkGeneric 12/2020
1	3- (5- tert- butylisoxazol- 3- yl)- 2- ((3- chlorophenyl)hydrazono)- 3- oxopropionitrileIBA 12/2020
1	Ceftriaxone (Ceftriaxon)FDA LinkGeneric 12/2020
1	Ferritins (Ferritin)IBA 12/2020
1	NivolumabIBA 01/2019
1	Member 1 Subfamily B ATP Binding Cassette TransporterIBA 01/2019
1	Etoposide (VP 16)FDA LinkGeneric 01/2019
1	Organic Anion TransportersIBA 01/2019
1	Oxidants (Oxidizing Agents)IBA 01/2019
1	Carboplatin (JM8)FDA LinkGeneric 01/2019
1	Antineoplastic Agents (Antineoplastics)IBA 01/2019
1	Cisplatin (Platino)FDA LinkGeneric 01/2019
1	glecaprevir and pibrentasvirIBA 01/2019
1	SteroidsIBA 01/2019
1	Pneumococcal Vaccines (Pneumococcal Polysaccharide Vaccine)IBA 01/2019
1	Sitagliptin Phosphate (Januvia)FDA Link 03/2018
1	Adenylyl Cyclases (Adenylyl Cyclase)IBA 11/2017
1	Adenosine Monophosphate (AMP)IBA 11/2017
1	Oxygen (Dioxygen)IBA 11/2017
1	Transcription Factors (Transcription Factor)IBA 11/2017
1	Cyclic AMP Response Element-Binding Protein (Cyclic AMP-Responsive DNA-Binding Protein)IBA 11/2017
1	Cyclic AMP-Dependent Protein Kinases (cAMP-Dependent Protein Kinase)IBA 11/2017
1	CCAAT-Enhancer-Binding ProteinsIBA 11/2017
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2017
1	naphthaleneIBA 10/2016

Therapy/Procedure

5	Therapeutics 12/2021 - 03/2016
4	Drug Therapy (Chemotherapy) 01/2022 - 12/2020
1	Immunotherapy 12/2021
1	Plasma Exchange 01/2021
1	Transition to Adult Care 07/2020
1	Transitional Care 07/2020
1	Patient Transfer (Patient Dumping) 07/2020
1	Renal Dialysis (Hemodialysis) 01/2019
1	Liver Transplantation 02/2018
1	Lung Transplantation 10/2016